Antiepileptic drugs are the first‐line treatment for trigeminal neuralgia (TN). Carbamazepine and oxcarbazepine are the most studied with well‐known efficacy. Eslicarbazepine acetate is a third‐generation antiepileptic drug that has not… Click to show full abstract
Antiepileptic drugs are the first‐line treatment for trigeminal neuralgia (TN). Carbamazepine and oxcarbazepine are the most studied with well‐known efficacy. Eslicarbazepine acetate is a third‐generation antiepileptic drug that has not previously been evaluated for the treatment of TN. We aim to assess the efficacy, tolerability and safety of eslicarbazepine for TN.
               
Click one of the above tabs to view related content.